###begin article-title 0
The Viral Oncoprotein LMP1 Exploits TRADD for Signaling by Masking Its Apoptotic Activity
###end article-title 0
###begin p 1
###xml 431 436 427 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 265 283 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 343 348 <span type="species:ncbi:9606">human</span>
The tumor necrosis factor (TNF)-receptor 1-associated death domain protein (TRADD) mediates induction of apoptosis as well as activation of NF-kappaB by cellular TNF-receptor 1 (TNFR1). TRADD is also recruited by the latent membrane protein 1 (LMP1) oncoprotein of Epstein-Barr virus, but its role in LMP1 signaling has remained enigmatic. In human B lymphocytes, we have generated, to our knowledge, the first genetic knockout of TRADD to investigate TRADD's role in LMP1 signal transduction. Our data from TRADD-deficient cells demonstrate that TRADD is a critical signaling mediator of LMP1 that is required for LMP1 to recruit and activate I-kappaB kinase beta (IKKbeta). However, in contrast to TNFR1, LMP1-induced TRADD signaling does not induce apoptosis. Searching for the molecular basis for this observation, we characterized the 16 C-terminal amino acids of LMP1 as an autonomous and unique virus-derived TRADD-binding domain. Replacing the death domain of TNFR1 by LMP1's TRADD-binding domain converts TNFR1 into a nonapoptotic receptor that activates NF-kappaB through a TRAF6-dependent pathway, like LMP1 but unlike wild-type TNFR1. Thus, the unique interaction of LMP1 with TRADD encodes the transforming phenotype of viral TRADD signaling and masks TRADD's pro-apoptotic function.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 149 167 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 169 172 <span type="species:ncbi:10376">EBV</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 314 317 <span type="species:ncbi:10376">EBV</span>
For viral infection to succeed, viral proteins must interact with the cellular signaling machinery of its target cell. An oncoprotein encoded by the Epstein-Barr virus (EBV) called latent membrane protein 1 (LMP1) is a primary contributor to the transformation of human B cells by the virus and the development of EBV-associated B cell malignancies by recruiting signaling molecules provided by the host. One such molecule, the cellular adapter protein TRADD, is among the few direct interaction partners of LMP1. But because TRADD promotes cell death (apoptosis) in the cellular tumor necrosis factor-receptor 1 (TNFR1) signaling pathway, it seems counterintuitive that TRADD could play a role in LMP1 biology, since LMP1 promotes cell survival and proliferation. We provide genetic evidence that TRADD is critical for LMP1 to assemble its transforming signaling network. LMP1 requires TRADD to recruit and activate I-kappaB kinase beta and, thus, to induce canonical NF-kappaB signaling. Simultaneously, LMP1 masks TRADD's pro-apoptotic activity. We show that LMP1 carries a unique and autonomous viral TRADD-binding domain, which dictates an unusual structure of the LMP1-TRADD complex and the nonapoptotic phenotype of TRADD signaling, irrespective of the receptor context in which this domain is located. Thus, DNA tumor viruses alter the functional properties of cellular signaling molecules to exploit them for their own purpose of cell transformation.
###end p 4
###begin p 5
A unique Epstein Barr virus-derived protein interaction domain uses the cellular death domain protein TRADD to assemble its transforming signaling complex and dictates a transferable nonapoptitic phenotype of TRADD signaling.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b001">1</xref>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b001">1</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b002">2</xref>
###xml 757 758 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b003">3</xref>
###xml 60 78 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 80 83 <span type="species:ncbi:10376">EBV</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 272 275 <span type="species:ncbi:10376">EBV</span>
###xml 348 363 <span type="species:ncbi:10090">transgenic mice</span>
Latent membrane protein 1 (LMP1) is the primary oncogene of Epstein-Barr virus (EBV), which is a human DNA tumor virus of the gamma-herpes virus family that preferentially infects and transforms human B lymphocytes [1]. LMP1 is critical for B lymphocyte transformation by EBV and has oncogenic potential when expressed in the B cell compartment of transgenic mice [1]. Despite the fact that LMP1 promotes cell survival and proliferation, it recruits the pro-apoptotic tumor necrosis factor (TNF)-receptor 1-associated death domain protein (TRADD) [2]. TRADD has been described as the central adapter protein of TNF-receptor 1 (TNFR1), and TRADD mediates TNFR1 induction of apoptosis as well as the activation of NF-kappaB and c-Jun N-terminal kinase (JNK) [3]. In contrast, the role of TRADD in LMP1 signaling has been unresolved.
###end p 7
###begin p 8
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b004">4</xref>
###xml 609 610 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b005">5</xref>
###xml 792 793 776 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b006">6</xref>
###xml 794 795 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b009">9</xref>
###xml 914 915 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b008">8</xref>
###xml 916 918 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b010">10</xref>
###xml 1133 1134 1099 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b008">8</xref>
###xml 1135 1136 1101 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b009">9</xref>
###xml 1137 1139 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b011">11</xref>
###xml 1301 1302 1255 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b008">8</xref>
###xml 1303 1305 1257 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b010">10</xref>
###xml 1430 1432 1384 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b012">12</xref>
###xml 1433 1435 1387 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b017">17</xref>
###xml 1524 1526 1474 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b015">15</xref>
###xml 1527 1529 1477 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b018">18</xref>
###xml 1655 1657 1601 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b010">10</xref>
###xml 1658 1660 1604 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b011">11</xref>
###xml 1661 1663 1607 1609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b019">19</xref>
###xml 1664 1666 1610 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b020">20</xref>
###xml 1902 1903 1848 1849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b005">5</xref>
###xml 2060 2062 2006 2008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b019">19</xref>
###xml 2063 2065 2009 2011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b021">21</xref>
###xml 1558 1563 <span type="species:ncbi:10090">mouse</span>
LMP1 is a transmembrane protein composed of 386 amino acids (aa) that mimics a constitutively active receptor [4]. Six transmembrane helices mediate the spontaneous formation of LMP1 oligomers in the membrane, which is an essential and sufficient prerequisite to induce signal transduction at the C-terminal cytoplasmic signaling domain (aa 186-386) of the molecule. Two functionally independent regions within the LMP1 signaling domain are involved in B lymphocyte growth transformation and the induction of signal transduction: the C-terminal activating region 1 (CTAR1, aa 194-231) and CTAR2 (aa 351-386) [5]. CTAR1 harbors a P(204)xQxT/S consensus motif, which binds TNFR-associated factors (TRAFs) and induces the noncanonical NF-kappaB pathway through I-kappaB kinase alpha (IKKalpha) [6-9]. CTAR2 triggers the canonical NF-kappaB pathway via IKKbeta followed by phosphorylation and degradation of I-kappaB [8,10]. Although IKKbeta has an indirect role in CTAR1 function, most likely by up-regulating the expression of critical factors for noncanonical NF-kappaB signaling, its kinase activity is primarily activated by CTAR2 [8,9,11]. IKKalpha rather acts as a negative regulator of CTAR2-induced NF-kappaB activity, whereas IKKgamma is required for some but not all canonical CTAR2 signaling [8-10]. The JNK pathway is generally triggered at CTAR2, although CTAR1 can also contribute to JNK activation in some cell lines [12-17]. The motif P(379)VQLSY(384) of CTAR2 is essential for activation of NF-kappaB and JNK [15,18]. Studies in TRAF-deficient mouse cells suggested critical roles of TRAF3 and TRAF6 in CTAR2 signaling to NF-kappaB and JNK [10,11,19,20], but it is still unclear how CTAR2 assembles its signaling complex. In contrast to CTAR1, TRAF molecules have no affinity for CTAR2. There is no experimental evidence for a direct or indirect physical interaction of CTAR2 with TRAF3 [5], but TRAF6 translocates to sites of active LMP1, and its indirect interaction with CTAR2 might involve the transcriptional corepressor BS69 as a mediator [19,21].
###end p 8
###begin p 9
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b002">2</xref>
###xml 428 429 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b002">2</xref>
###xml 430 432 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b015">15</xref>
###xml 512 514 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b014">14</xref>
###xml 799 801 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b011">11</xref>
###xml 802 804 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b019">19</xref>
###xml 1074 1076 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b014">14</xref>
###xml 1354 1356 1338 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b010">10</xref>
###xml 1357 1359 1341 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b019">19</xref>
###xml 1360 1362 1344 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b020">20</xref>
###xml 78 83 <span type="species:ncbi:4932">yeast</span>
During the search of CTAR2-binding proteins, TRADD has been pulled out from a yeast-two-hybrid screen using CTAR2 as a bait [2]. Early experiments have indicated a potential role for TRADD in LMP1 signaling. Overexpression of TRADD potentiated NF-kappaB activation by LMP1 in HEK293 epithelial cells, and co-expression of TRADD harboring a mutated death domain interfered with LMP1 signaling to NF-kappaB in the same cell line [2,15]. A role for TRADD in CTAR2-triggered JNK activation has also been postulated [14]. However, it cannot be excluded that TRADD overexpression caused unspecific effects unrelated to LMP1 signaling in these studies. More recent experiments showed no significant effect of RNAi-mediated TRADD down-regulation on CTAR2-induced NF-kappaB and JNK activity in HEK293 cells [11,19]. Therefore, it is currently believed that TRADD is dispensable for LMP1 signaling, and no molecular role of TRADD in organizing the CTAR2 signaling complex has been demonstrated. In analogy to TNFR1 signaling, it has been suggested that TRADD recruits TRAF2 to CTAR2 [14]. However, no experimental evidence for a physical interaction of TRAF2 with the signaling complex at CTAR2 is available. Recent data from TRAF2-deficient cell lines and RNAi experiments showed that TRAF2 is fully dispensable for activation of NF-kappaB and JNK by LMP1-CTAR2 [10,19,20]. Until today, no definite evidence for a role of TRADD in LMP1 signaling has been provided due to the lack of TRADD-deficient animals or cell lines.
###end p 9
###begin p 10
###xml 150 152 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b022">22</xref>
###xml 310 312 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b023">23</xref>
###xml 663 665 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b015">15</xref>
###xml 926 927 918 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b002">2</xref>
Upon activation with the pro-inflammatory cytokine TNFalpha, TNFR1 recruits TRADD via direct interaction between the death domains of both molecules [22]. TRADD is believed to serve as a platform for the binding of TRAF2 and RIP1 to set up the TNFR1 complex at the plasma membrane, inducing JNK and NF-kappaB [23]. Subsequently, TRADD binds the Fas-associated death domain protein (FADD) to activate caspase 8-dependent apoptosis. In contrast to TNFR1, LMP1 is devoid of a death domain, and TRADD's death domain is dispensable for TRADD interaction with LMP1, suggesting that the molecular architectures of the TNFR1-TRADD and LMP1-TRADD complexes are different [15]. However, it is unknown whether this unique type of TRADD recruitment is determined by LMP1 and whether it has relevance for the biological function of LMP1. Although amino acid residues Y384 and Y385 of CTAR2 are known to be essential for TRADD recruitment [2], the functional TRADD-binding site of LMP1 has not been well defined.
###end p 10
###begin p 11
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 108 113 <span type="species:ncbi:9606">human</span>
Here, we report the first genetic knockout, to our knowledge, of the TRADD gene, which we have generated in human B lymphocytes to characterize TRADD's role in LMP1 signal transduction. Using TRADD-deficient cells, we found that TRADD has an essential role in LMP1 activation of canonical NF-kappaB signaling by mediating the recruitment and activation of IKKbeta. In contrast, JNK induction by LMP1 is independent of TRADD, demonstrating that the NF-kappaB and JNK pathways bifurcate upstream of TRADD at the level of CTAR2. We narrowed down the functional TRADD-binding domain of LMP1 to the 16 C-terminal amino acids of LMP1. The deletion of this domain resulted in a loss of IKKbeta binding to LMP1. We were able to transplant the nonapoptotic phenotype of LMP1-induced TRADD signaling to TNFR1 by replacing its death domain by the TRADD-binding sequence of LMP1. Thus, the viral oncoprotein LMP1 exploits TRADD for nonapoptotic signaling, which is intrinsically encoded by the viral TRADD-binding domain but not by the receptor context in which it operates.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 29 34 <span type="species:ncbi:9606">Human</span>
Somatic Knockout of TRADD in Human B Lymphocytes
###end title 13
###begin p 14
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 480 485 480 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 600 605 600 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 637 642 637 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 688 693 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 728 736 728 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g001">Figure 1</xref>
###xml 826 831 826 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 889 894 889 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 1047 1053 1047 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD&#8211;</italic>
###xml 1116 1124 1116 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g001">Figure 1</xref>
###xml 1249 1254 1249 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 1288 1296 1288 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060008-st001">Table S1</xref>
###xml 1440 1445 1440 1445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 1455 1463 1455 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060008-st001">Table S1</xref>
###xml 1522 1528 1522 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD&#8211;</italic>
###xml 1539 1547 1539 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g001">Figure 1</xref>
###xml 1556 1561 1556 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 174 179 <span type="species:ncbi:9606">human</span>
###xml 233 236 <span type="species:ncbi:10376">EBV</span>
###xml 296 299 <span type="species:ncbi:10376">EBV</span>
###xml 309 314 <span type="species:ncbi:9606">human</span>
###xml 474 479 <span type="species:ncbi:9606">human</span>
###xml 707 712 <span type="species:ncbi:9606">human</span>
Studies on the role of TRADD in LMP1 signaling were hampered by the lack of TRADD-deficient mice or cell lines. To solve this problem, we chose to delete the TRADD gene from human B lymphocytes, which are the primary target cells of EBV and, thus, the natural compartment of LMP1 expression. The EBV-negative human B cell lines DG75, BJAB, and BL2 were selected as candidates for the TRADD knockout due to their diploidy of the TRADD locus (unpublished data). We cloned the human TRADD gene from a genomic blood cell DNA library in order to construct the two gene targeting vectors pTRADDko.1 (first TRADD allele) and pTRADDko.2 (second TRADD allele) for the consecutive deletion of both TRADD alleles from human somatic cells (Figure 1A and Materials and Methods). Both constructs differed in their 3' arms homologous to the TRADD gene to prevent recombination with the already disrupted TRADD allele while targeting the second allele. In DG75 cells, each step of the gene targeting procedure was verified by Southern blotting, resulting in DG75 TRADD-/- clones with no encoding TRADD sequences left in the genome (Figure 1B). In contrast to DG75 cells, BJAB and BL2 cells did not support homologous recombination of the targeting vectors with the TRADD locus at a detectable frequency (Table S1). The targeting efficiency in DG75 cells was approximately one out of 50 GFP-positive, hygromycin B- and ganciclovir-resistant clones for both TRADD alleles (Table S1). As expected, no TRADD protein was expressed in the DG75 TRADD-/- clones (Figure 1C). DG75 TRADD-/- cells were fully viable and showed similar growth properties to wild-type cells at normal cell densities.
###end p 14
###begin title 15
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 24 29 <span type="species:ncbi:9606">Human</span>
TRADD Gene Targeting in Human DG75 B Lymphocytes
###end title 15
###begin p 16
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 297 300 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 328 332 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
(A) Knockout strategy. Given base positions relate to the transcriptional start site at position +1. The complete TRADD open reading frame (black boxes, exons 2-5 with ATG at position +3218) was deleted by homologous recombination with pTRADDko.1 (first allele) and pTRADDko.2 (second allele). C, CMV promoter; P, promoter; SV, SV40 promoter; TK, thymidine kinase.
###end p 16
###begin p 17
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
(B) Southern blot analysis of the resulting DG75 clones with EcoRI-digested chromosomal DNA and the external probe 1. The genealogy of clones is illustrated by arrows. WT, TRADD wild-type allele; KO, targeted and Cre-deleted alleles 1 or 2, respectively.
###end p 17
###begin p 18
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
(C) TRADD protein expression. Immunoblot analysis using the mouse anti-TRADD antibody.
###end p 18
###begin title 19
TRADD Mediates IKKbeta Activation by LMP1
###end title 19
###begin p 20
###xml 116 118 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b022">22</xref>
###xml 119 121 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b024">24</xref>
###xml 149 155 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD&#8211;</italic>
###xml 248 253 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 261 267 257 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD&#8211;</italic>
###xml 357 365 345 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g002">Figure 2</xref>
###xml 289 294 <span type="species:ncbi:9606">human</span>
TRADD overexpression and RNAi studies have suggested that TRADD mediates TNFR1 activation of the NF-kappaB pathway [22,24]. To demonstrate that DG75 TRADD-/- cells are suitable tools to study the role of TRADD in signal transduction, we stimulated TRADD+/+ and TRADD-/- cells with soluble human TNFalpha and monitored the activity of the NF-kappaB pathway (Figure 2A). DG75 wild-type cells responded to TNFalpha stimulation with a rapid phosphorylation and subsequent degradation of I-kappaB. In contrast, the knockout of TRADD completely abolished TNFalpha-induced I-kappaB phosphorylation. This result delivered genetic evidence for an essential role of TRADD in TNFR1 signaling to NF-kappaB and showed that canonical NF-kappaB signaling is intact in DG75 cells.
###end p 20
###begin title 21
TRADD Is Essential for IKKbeta Activation by LMP1, but It Is Dispensable for JNK Induction
###end title 21
###begin p 22
###xml 106 111 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 118 123 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 163 165 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 174 179 <span type="species:ncbi:9606">human</span>
(A) The knockout of TRADD in DG75 B lymphocytes abolishes TNFR1 activation of the NF-kappaB pathway. DG75 TRADD+/+ or TRADD-/- cells were stimulated with 200 ng ml-1 soluble human TNFalpha (Roche) for the indicated times. Levels of phospho-I-kappaB and I-kappaB were analyzed on immunoblots. alphaTubulin served as the loading control.
###end p 22
###begin p 23
###xml 52 57 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 64 69 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 426 428 <span type="species:ncbi:34205">M2</span>
(B) LMP1 activation of IKKbeta requires TRADD. DG75 TRADD+/+ or TRADD-/- cells were electroporated with the indicated LMP1 constructs and Flag-IKKbeta. Flag-IKKbeta activity was monitored in immunocomplex kinase assays. GST-I-kappaBalpha phosphorylation was quantified by a phosphoimager and is given as x-fold induction. Immunoprecipitated Flag-IKKbeta and the expressed HA-LMP1 constructs were detected using the anti-Flag (M2) and anti-HA (12CA5) antibodies, respectively. LMP1-CD40 was visualized by the anti-CD40 antibody. IB, immunoblot; IP, immunoprecipitation.
###end p 23
###begin p 24
###xml 286 291 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 311 316 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 280 285 <span type="species:ncbi:9606">human</span>
(C) Ectopic TRADD expression rescues LMP1 activation of IKKbeta in TRADD-/- cells. IKKbeta assays were performed in DG75 TRADD-/- cells as in (B). Where indicated, TRADD was expressed at physiological levels by co-transfecting 1 mug of pACYC184-1012.4, which carries the complete human TRADD gene including the TRADD promoter.
###end p 24
###begin p 25
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
(D) JNK1 activation by LMP1 is independent of TRADD. HA-JNK1 immunocomplex kinase assays in DG75 TRADD+/+ and TRADD-/- cells are shown. Immunoprecipitated HA-JNK1 was dectected with the anti-JNK1 (C17) antibody.
###end p 25
###begin p 26
###xml 132 133 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b008">8</xref>
###xml 134 136 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b010">10</xref>
###xml 137 139 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b011">11</xref>
###xml 263 268 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 276 282 258 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD&#8211;</italic>
###xml 401 409 376 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g002">Figure 2</xref>
###xml 810 815 770 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 912 920 861 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g002">Figure 2</xref>
###xml 1054 1059 996 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 1150 1158 1089 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g002">Figure 2</xref>
###xml 1552 1557 1488 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 1565 1571 1501 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD&#8211;</italic>
 TRADD interacts with the CTAR2 domain of LMP1, which signals through IKKbeta to activate the I-kappaB-dependent NF-kappaB pathway [8,10,11]. To investigate a potential role of TRADD in LMP1-induced NF-kappaB signaling, we performed IKKbeta kinase assays in DG75 TRADD+/+ and TRADD-/- cells, because IKKbeta activity is the most proximal and specific readout of CTAR2 signaling on the NF-kappaB axis (Figure 2B). Due to the high endogenous NF-kappaB activity levels in DG75 cells, NF-kappaB reporter gene assays did not result in reliable induction levels after LMP1 expression (unpublished data). HA-LMP1Delta371-386, which lacks the 16 C-terminal amino acids of LMP1, is defective in CTAR2 signaling and served as null control. Expression of wild-type HA-LMP1 resulted in a 2.8-fold activation of IKKbeta in TRADD+/+ cells, monitored as I-kappaBalpha substrate phosphorylation and IKKbeta autophosphorylation (Figure 2B). Thus, CTAR2 triggered canonical NF-kappaB signaling in wild-type cells. Strikingly, CTAR2 lost its potential to induce IKKbeta in TRADD-/- cells, which clearly showed that CTAR2 requires TRADD to activate the IKKbeta pathway (Figure 2B). To demonstrate specificity of this effect for LMP1, we analyzed CD40 signaling in wild-type and TRADD-deficient cells. CD40 does not recruit TRADD and was therefore anticipated to signal also in the absence of TRADD. Confirming this presumption, a constitutively active chimera composed of the LMP1 transmembrane domain and the CD40 signaling domain, LMP1-CD40, induced IKKbeta activity in TRADD+/+ and TRADD-/- cells to similar levels.
###end p 26
###begin p 27
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 215 223 212 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g002">Figure 2</xref>
###xml 269 275 266 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD&#8211;</italic>
###xml 370 375 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 431 452 428 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 698 704 689 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD&#8211;</italic>
###xml 789 797 776 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g002">Figure 2</xref>
###xml 364 369 <span type="species:ncbi:9606">human</span>
To exclude that defects unrelated to TRADD had caused the defective LMP1 signaling in DG75 TRADD-/- cells, we tested whether ectopic expression of TRADD restored LMP1 activation of IKKbeta in TRADD-deficient cells (Figure 2C). To express TRADD at physiological levels, TRADD-/- cells were co-transfected with the pACYC184-1012.4 vector, which carries the complete human TRADD gene under the control of its endogenous promoter (see Materials and Methods). Exogenous TRADD expression alone did not induce IKKbeta, further confirming that TRADD protein levels lay within a normal range which did not result in TRADD autoactivation. Notably, reintroduction of TRADD enabled LMP1 to activate IKKbeta in TRADD-/- cells, verifying TRADD's essential role in CTAR2 signaling on the NF-kappaB axis (Figure 2C). In summary, our results provided strong genetic evidence for a critical role of TRADD in LMP1 signal transduction. In fact, LMP1 requires TRADD to induce the IKKbeta/NF-kappaB pathway.
###end p 27
###begin title 28
NF-kappaB and JNK Signaling Bifurcate Upstream of TRADD
###end title 28
###begin p 29
###xml 245 253 245 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g002">Figure 2</xref>
###xml 510 515 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 646 651 642 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 718 726 714 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g002">Figure 2</xref>
To further dissect the signaling pathways originating at CTAR2, we tested whether the LMP1-induced JNK pathway required TRADD for its activation. Both HA-LMP1 and LMP1-CD40 readily activated JNK in HA-JNK1 kinase assays in DG75 wild-type cells (Figure 2D). CTAR2 but not CTAR1 triggers JNK activation in DG75 cells, because mutation of Y384 to G within CTAR2 fully abrogated JNK activation as compared with the LMP1Delta194-386 control, which lacks the complete signaling domain. By analyzing JNK signaling in TRADD-/- cells, we observed that CD40 activation of JNK1 was independent of TRADD, as expected. Surprisingly, also LMP1 induced JNK1 in TRADD-/- cells to levels that were similar to those of wild-type cells (Figure 2D). Thus, activation of the JNK pathway by LMP1 does not involve TRADD, demonstrating that the CTAR2-triggered NF-kappaB and JNK pathways bifurcate upstream of TRADD at the level of CTAR2.
###end p 29
###begin title 30
TRADD Is Required for IKKbeta Interaction with the LMP1 Signaling Complex at CTAR2
###end title 30
###begin p 31
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b003">3</xref>
###xml 245 247 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b025">25</xref>
###xml 248 250 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b027">27</xref>
###xml 350 352 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b028">28</xref>
###xml 613 615 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b010">10</xref>
###xml 616 618 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b029">29</xref>
In TNFR1 signaling, TRADD mediates TRAF2 and probably also RIP1 binding to the activated signaling complex [3]. Subsequently, the IKK complex is recruited to the receptor through interactions of IKKalpha/beta with TRAF2, and IKKgamma with RIP1 [25-27]. Activation of IKKs is achieved through the TAB2/TAK1 complex, which binds to ubiquitinated RIP1 [28]. We show here that TRADD is necessary for IKKbeta activation by the CTAR2 domain of LMP1. However, TRAF2/5, RIP1, TAB2, and IKKgamma-the key players of TRADD signaling to NF-kappaB in the TNFR1 context-are all dispensable for LMP1-induced NF-kappaB activity [10,29]. This raised a question about the molecular function of TRADD in the LMP1 pathway to IKKbeta.
###end p 31
###begin p 32
###xml 207 215 204 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g003">Figure 3</xref>
###xml 261 266 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 752 757 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 768 776 746 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g003">Figure 3</xref>
To examine whether LMP1 recruits IKKbeta and to evaluate whether TRADD has a role in this process, we performed co-immunoprecipitation assays with HA-tagged LMP1 in DG75 wild-type and TRADD-deficient cells (Figure 3A). IKKbeta co-precipitated with HA-LMP1 from TRADD+/+ cells. Thus, IKKbeta physically interacts with the LMP1 signaling complex. In addition, we found that TRADD was present in the complex together with HA-LMP1 and IKKbeta. Deletion of the 16 C-terminal amino acids of LMP1 resulted in a loss of TRADD and IKKbeta interaction with LMP1, demonstrating that aa 371-386 of LMP1 are essential for the recruitment of the NF-kappaB-inducing signaling complex to CTAR2. Remarkably, IKKbeta was absent in HA-LMP1 immunoprecipitations from DG75 TRADD-/- cells (Figure 3A). These data support an essential role of TRADD in mediating the binding of IKKbeta to the LMP1 signaling complex at CTAR2. In contrast to TRADD and IKKbeta, we could not detect a physical interaction of TRAF3 or TRAF6 with CTAR2 in our immunoprecipitations from DG75 cells (unpublished data), making it unlikely that both TRAFs have crucial roles in the binding of IKKbeta to CTAR2.
###end p 32
###begin title 33
TRADD Mediates the Interaction of IKKbeta with CTAR2
###end title 33
###begin p 34
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 427 432 <span type="species:ncbi:10090">mouse</span>
(A) DG75 TRADD+/+ or TRADD-/- cells were electroporated with the indicated HA-LMP1 constructs and Flag-IKKbeta. Twenty-four h post transfection, the LMP1 signaling complex was immunoprecipitated using the anti-HA (12CA5) antibody, which was covalently coupled to protein A sepharose beads. Precipitated HA-LMP1 proteins were detected by the anti-HA (12CA5) antibody, and IKKbeta and TRADD were detected by the anti-IKKbeta and mouse anti-TRADD antibodies, respectively.
###end p 34
###begin p 35
###xml 135 140 <span type="species:ncbi:9606">human</span>
###xml 173 176 <span type="species:ncbi:10376">EBV</span>
###xml 474 479 <span type="species:ncbi:10090">mouse</span>
###xml 498 504 <span type="species:ncbi:9986">rabbit</span>
(B) IKKbeta interacts with the LMP1 signaling complex in lymphoblastoid cells. LCL 3 cells were generated by transformation of primary human B cells with a recombinant maxi-EBV, in which the wild-type LMP1 gene had been replaced by HA-tagged LMP1. HA-LMP1 was immunoprecipitated from LCL 3 lysates using anti-HA (12CA5) beads. Parallel immunoprecipitations from LCL 721 cells expressing untagged LMP1 served as a negative control. Precipitated proteins were detected by the mouse anti-LMP1 and the rabbit anti-IKKbeta antibodies.
###end p 35
###begin p 36
###xml 110 118 107 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g003">Figure 3</xref>
###xml 404 412 401 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g003">Figure 3</xref>
###xml 60 63 <span type="species:ncbi:10376">EBV</span>
###xml 148 153 <span type="species:ncbi:9606">human</span>
###xml 203 206 <span type="species:ncbi:10376">EBV</span>
Next, we tested whether IKKbeta also interacts with LMP1 in EBV-transformed lymphoblastoid cell lines (LCLs) (Figure 3B). For this purpose, primary human B cells were transformed with a recombinant maxi-EBV, which carried HA-LMP1 instead of the wild-type LMP1 gene. The resulting lymphoblastoid cell line LCL 3 endogenously expressed HA-LMP1 at levels comparable to untagged LMP1 of the control LCL 721 (Figure 3B). Endogenous IKKbeta co-precipitating with HA-LMP1 was detected in anti-HA immunoprecipitations from HA-LMP1 cells (LCL 3, right panel) but not from LMP1 cells which served as a control for the specificity of anti-HA immunoprecipitation (LCL 721, left panel). These data verified the physical interaction of endogenous IKKbeta with the LMP1 signaling complex also in LCLs.
###end p 36
###begin title 37
LMP1 AA 371-386 Comprise a Unique and Transferable TRADD Binding Site
###end title 37
###begin p 38
###xml 227 235 223 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g005">Figure 5</xref>
###xml 238 240 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b029">29</xref>
###xml 318 326 314 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g005">Figure 5</xref>
###xml 329 331 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b024">24</xref>
###xml 332 334 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b030">30</xref>
Here we provide evidence for an active role of TRADD in LMP1 signal transduction. Nevertheless, LMP1 has anti-apoptotic properties, and LMP1 signaling does not trigger cell death, even if the NF-kappaB pathway is blocked (see: Figure 5) [29]. In contrast, TNFR1 induces caspase-dependent apoptosis through TRADD (see: Figure 5) [24,30]. The TRADD interaction sites of LMP1 and TNFR1 are not related, because LMP1 has no death domain to bind TRADD. Based on these observations, we asked whether the unique TRADD-binding site of LMP1 might determine the non-apoptotic phenotype of virus-induced TRADD signaling. Alternatively, the receptor context of LMP1's TRADD-binding domain might dictate the outcome of TRADD signaling. To answer this question, we transferred LMP1's TRADD-binding domain into the context of the TNFR1 signaling domain and evaluated the apoptotic potential of the resulting chimera.
###end p 38
###begin title 39
LMP1's TRADD-Binding Domain (LTB) Induces LMP1-Type Signaling but Does Not Activate Apoptosis in the Context of the TNFR1 Signaling Domain
###end title 39
###begin p 40
(A) The LTB is functional in the context of the TNFR1 signaling domain. NF-kappaB reporter assays in HEK293 cells. Data are mean values of three independent experiments +/- standard deviation.
###end p 40
###begin p 41
###xml 293 294 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
(B) The transferred LTB determines TRAF6-dependent NF-kappaB activation. NF-kappaB reporter assays in TRAF6-/- MEFs are shown. Where indicated (black bars), TRAF6 was co-transfected. Data are mean values of four independent experiments +/- standard deviation; statistics: two-tailed Student's t-test.
###end p 41
###begin p 42
###xml 116 121 <span type="species:ncbi:9606">human</span>
(C) Lack of apoptosis induction by LTB in the context of the TNFR1 signaling domain. Transient cell death assays in human BJAB B lymphocytes are shown. The NF-kappaB pathway was blocked by co-expression of domaint-negative I-kappaBalpha(S32/36A). Where indicated, the cells were incubated in the presence of 2 muM zVAD-fmk (zVAD), a pan-caspase inhibitor. PI, propidium iodide. Data are mean values of three independent experiments +/- standard deviation.
###end p 42
###begin p 43
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 242 243 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
(D) Apoptosis induction by LMP1-TNFR1 is dependent on TRADD. Cell death assays in DG75 TRADD+/+ and DG75 TRADD-/- cells are shown. Data are mean values of three independent experiments +/- standard deviation; statistics: two-tailed Student's t-Test.
###end p 43
###begin p 44
###xml 62 70 62 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g003">Figure 3</xref>
###xml 365 373 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g004">Figure 4</xref>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b004">4</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b031">31</xref>
###xml 817 825 817 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g004">Figure 4</xref>
Amino acids 371-386 of LMP1 were essential for TRADD-binding (Figure 3A). We speculated that this motif might also be sufficient for TRADD interaction and, thus, contains the functional LMP1 TRADD-binding site (LTB). Therefore, we replaced the TNFR1 death domain of the HA-tagged LMP1-TNFR1 chimera by LMP1 aa 371-386, resulting in the construct HA-LMP1-TNFR1-LTB (Figure 4A). Due to spontaneous oligomerization of the LMP1 transmembrane part of the molecule, HA-LMP1-TNFR1 and its derivatives induce constitutive signaling specified by the type of fused signaling domain [4,31]. Thereby, all chimeras based upon HA-LMP1-TNFR1 are independent of a ligand and their signaling readouts can be directly compared with HA-LMP1. HA-LMP1, HA-LMP1-TNFR1, and all derivatives were expressed to similar levels in HEK293 cells (Figure 4B).
###end p 44
###begin title 45
Amino Acids 371-386 of LMP1 Encompass the Functional TRADD-Binding Domain
###end title 45
###begin p 46
(A) Domain swapping constructs. HA-LMP1-TNFR1 is a chimera of the LMP1 transmembrane domain and the signaling domain of TNFR1. HA-LMP1-TNFR1DeltaDD lacks the TNFR1 death domain (DD). HA-LMP1-TNFR1-LTB carries aa 371-386 of LMP1 instead of the TNFR1 death domain. EC, extracellular domain; LTB, LMP1 TRADD-binding domain; TM, transmembrane domain; wt, wild type.
###end p 46
###begin p 47
(B) Expression in HEK293 cells. Cells were lysed in the presence of 0.1% NP40, and proteins were detected on immunoblots of total cell lysates by the anti-HA (12CA5) antibody.
###end p 47
###begin p 48
(C) TRADD recruitment into lipid rafts. HEK293 cells were transfected with the indicated constructs together with expression vectors for TRADD and p35. Twenty-four h post transfection, lipid rafts were isolated. Fraction 2 contains lipid rafts (R), as detected on dot blots by the raft marker GM1. The anti-TRADD (H278) and anti-HA (12CA5) antibodies were used to visualize TRADD and HA-tagged constructs on immunoblots, respectively.
###end p 48
###begin p 49
###xml 360 365 <span type="species:ncbi:10090">mouse</span>
(D) Replacing the TNFR1 death domain, aa 371-386 of LMP1 are sufficient to recruit TRADD to the TNFR1 signaling domain. HEK293 cells were transfected with the indicated constructs together with expression vectors for TRADD wild type and p35. The HA-tagged constructs (asterisks) were immunoprecipitated via HA and detected by the anti-HA (12CA5) antibody. The mouse anti-TRADD antibody was used to stain TRADD. IP, immunoprecipitation; wt, wild type.
###end p 49
###begin p 50
(E) Interaction of LTB with TRADD is independent of a functional TRADD death domain. TRADD(296-299A) was co-transfected together with the indicated contructs. TRADD(296-299A) was detected by the anti-TRADD (H278) antibody. n.s., non-specific band.
###end p 50
###begin p 51
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b023">23</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b032">32</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b033">33</xref>
###xml 396 404 396 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g004">Figure 4</xref>
###xml 1284 1292 1280 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g004">Figure 4</xref>
First, it was important to show that aa 371-386 of LMP1 were sufficient to mediate TRADD interaction. Both, LMP1 and TNFR1 partially localize to, and signal from, membrane lipid rafts [23,32,33]. Therefore, we tested if HA-LMP1-TNFR1-LTB recruited TRADD into lipid rafts in HEK293 cells. A substantial fraction of HA-LMP1, HA-LMP1-TNFR1, and its derivatives localized to the lipid raft fraction (Figure 4C). Because of a reduced solubility of HA-LMP1-TNFR1 in Triton X-100 (unpublished data), this assay delivered qualitative rather than quantitative data regarding the amounts of expressed HA-LMP1-TNFR1 and its derivatives. HA-LMP1 recruited TRADD to rafts. Also HA-LMP1-TNFR1 relocated a major fraction of TRADD into this signaling-active compartment of the membrane. The deletion of the TNFR1 death domain completely abolished the ability of HA-LMP1-TNFR1 to interact with TRADD, as was shown by the absent shift of TRADD into the raft fraction in the presence of HA-LMP1-TNFR1DeltaDD. From this observation, we also concluded that aa 206-331 of the TNFR1 signaling domain were not sufficient to mediate TRADD binding to TNFR1. When we replaced the death domain of TNFR1 by aa 371-386 of LMP1, the resulting HA-LMP1-TNFR1-LTB chimera efficiently recruited TRADD into lipid rafts (Figure 4C). This result showed that the 16 C-terminal amino acids of LMP1 are not only essential but also sufficient for TRADD interaction and, thus, comprise the functional TRADD-binding domain of LMP1.
###end p 51
###begin p 52
###xml 197 205 193 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g004">Figure 4</xref>
###xml 341 349 337 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g004">Figure 4</xref>
To further substantiate our findings, we performed immunoprecipitation assays in HEK293 cells. Wild-type TRADD co-precipitated with HA-LMP1, whereas HA-LMP1-TNFR1DeltaDD failed to pull down TRADD (Figure 4D). Confirming aa 371-386 as the self-sufficient TRADD-binding site of LMP1, TRADD bound to HA-LMP1-TNFR1-LTB and HA-LMP1 equally well (Figure 4D).
###end p 52
###begin p 53
###xml 254 256 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b015">15</xref>
###xml 257 259 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b034">34</xref>
###xml 471 479 467 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g004">Figure 4</xref>
###xml 725 733 721 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g004">Figure 4</xref>
Mutation of aa 296-299 to alanines in TRADD's death domain strongly impaired TRADD binding to TNFR1 as well as TRADD activation of NF-kappaB, but had no negative effect on TRADD's interaction with LMP1 in glutathione S-transferase (GST) pulldown assays [15,34]. To evaluate whether this unique type of interaction between LMP1 and TRADD is encoded by the TRADD-binding site of LMP1, we tested if TRADD (296-299A) interacted with HA-LMP1-TNFR-LTB in immunoprecipitations (Figure 4E). HA-LMP1 efficiently bound TRADD (296-299A). After its transfer into the context of the TNFR1 signaling domain, the TRADD-binding site of LMP1 was still able to recruit TRADD (296-299A), albeit to a somewhat lesser extend than wild-type LMP1 (Figure 4E). Taken together, these experiments showed that aa 371-386 of LMP1 compose an autonomous viral TRADD-binding domain, which determines the unique type of interaction with TRADD, irrespective of the neighboring receptor context.
###end p 53
###begin title 54
The Viral TRADD Binding Site of LMP1 Determines Nonapoptotic TRADD Signaling
###end title 54
###begin p 55
###xml 155 163 155 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g005">Figure 5</xref>
###xml 858 867 846 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060008-sg001">Figure S1</xref>
###xml 1067 1075 1047 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g005">Figure 5</xref>
Next, we tested if the TRADD-binding site of LMP1 not only recruited TRADD when replacing the death domain of TNFR1, but also induced signal transduction (Figure 5A). Expression of wild-type HA-LMP1 caused a 17.0-fold induction of NF-kappaB activity in HEK293 cells. The contribution of CTAR2 was a 6.4-fold NF-kappaB activation, as determined by transfection of HA-LMP1(AAA), which carries an inactivating P(204)xQxT to AxAxA mutation in its CTAR1 domain. The HA-LMP1-TNFR1-LTB chimera also activated NF-kappaB to levels that were comparable to HA-LMP1(AAA), demonstrating that aa 371-386 of LMP1 retained their full competence to induce signal transduction after the transfer to the TNFR1 signaling domain. In addition, also JNK1 was activated by the HA-LMP1-TNFR1-LTB chimera, further confirming the functionality of LTB in the HA-LMP1-TNFR1-LTB chimera (Figure S1). The TRADD-binding site of LMP1 induced similar NF-kappaB levels as the TNFR1 death domain, demonstrating that both TRADD-binding domains are equally efficient with respect to NF-kappaB activation (Figure 5A).
###end p 55
###begin p 56
###xml 73 75 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b010">10</xref>
###xml 76 78 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b011">11</xref>
###xml 79 81 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b021">21</xref>
###xml 386 391 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRAF6</italic>
###xml 451 459 439 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g005">Figure 5</xref>
###xml 395 400 <span type="species:ncbi:10090">mouse</span>
In contrast to TNFR1, LMP1 signaling to NF-kappaB is dependent on TRAF6 [10,11,21]. To show that LMP1 aa 371-386 induced LMP1-type signaling in the context of the TNFR1 signaling domain, we evaluated if HA-LMP1-TNFR1-LTB activation of NF-kappaB is dependent on TRAF6. In contrast to HA-LMP1-TNFR1, the HA-LMP1-TNFR1-LTB chimera indeed required the reconstitution of TRAF6 expression in TRAF6-/- mouse embryonic fibroblasts (MEFs) to induce NF-kappaB (Figure 5B). Taken together, these results indicate that the TRADD-binding site of LMP1 was fully functional in the context of the TNFR1 signaling domain and encoded an LMP1-type signaling and interaction with TRADD.
###end p 56
###begin p 57
###xml 399 407 387 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g005">Figure 5</xref>
###xml 703 711 691 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g005">Figure 5</xref>
###xml 802 810 790 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g005">Figure 5</xref>
###xml 931 933 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b024">24</xref>
###xml 1106 1114 1094 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g005">Figure 5</xref>
###xml 170 175 <span type="species:ncbi:9606">human</span>
Finally, we investigated whether the TRADD-binding site of LMP1 had the potential to induce cell death in the context of the TNFR1 signaling domain. Cell death assays in human BJAB B lymphocytes showed that expression of wild-type HA-LMP1 did not interfere with cell survival in the absence of NF-kappaB signaling, which was inhibited by co-transfection of dominant-negative I-kappaBalpha(S32/36A) (Figure 5C). In contrast, TNFR1 signaling induced by HA-LMP1-TNFR1 strongly reduced the survival rate of BJAB cells to 45.3 % of the controls. Cell death induced by HA-LMP1-TNFR1 was caspase-dependent, because the pan-caspase inhibitor zVAD-fmk fully rescued cell survival after HA-LMP1-TNFR1 expression (Figure 5C). Moreover, HA-LMP1-TNFR1 required TRADD to exert its killing activity in B lymphocytes (Figure 5D). Because TNFR1 has been demonstrated to induce apoptosis specifically through a TRADD- and caspase-dependent pathway [24], HA-LMP1-TNFR1-induced cell death is most likely due to apoptosis. Most notably and in contrast to HA-LMP1-TNFR1, the HA-LMP1-TNFR1-LTB chimera did not induce cell death (Figure 5C). Thus, although being fully functional with regard to the binding of TRADD and the induction of signal transduction, the TRADD-binding site of LMP1 had no apoptotic potential in the context of the TNFR1 signaling domain. We concluded from these results that the unique TRADD-binding site of LMP1, but not the context of the receptor signaling domain, encodes the nonapoptotic type of viral TRADD signaling.
###end p 57
###begin title 58
The TRADD-Binding Site of LMP1 Converts TNFR1 into a Nonapoptotic Receptor
###end title 58
###begin p 59
###xml 137 145 137 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g006">Figure 6</xref>
###xml 427 435 423 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g006">Figure 6</xref>
###xml 902 910 894 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g006">Figure 6</xref>
###xml 1257 1265 1249 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g006">Figure 6</xref>
To further corroborate our findings, we transferred LMP1 aa 371-386 into the context of wild-type TNFR1, replacing TNFR1's death domain (Figure 6A). The resulting chimera, TNFR1-LTB, was devoid of any other LMP1 sequences except of LMP1's TRADD-binding site. TNFR1DeltaDD lacking its death domain served as a control. After electroporation, all constructs were expressed to similar levels in TNFR1/TNFR2-double deficient MEFs (Figure 6B). We used TNFR-deficient cells for our experiments to avoid cross-talk or the formation of heterocomplexes between the exogenously expressed TNFR1-LTB chimera and endogenous wild-type TNF-receptors. Activation of the TNFR1 constructs was achieved by spontaneous patching upon high exogenous expression in TNFR-deficient cells. Both, TNFR1 and TNFR1-LTB induced NF-kappaB to comparable levels in TNFR-deficient MEFs in the presence or absence of caspase inhibition (Figure 6C). Thus, the TRADD-binding domain of LMP1 was functional also in the context of wild-type TNFR1. However, whereas TNFR1 expression resulted in a massive induction of caspase-dependent apoptosis in TNFR-deficient MEFs, TNFR1-LTB did not affect viability, even if TNFR1-LTB was transfected at 5-fold higher DNA concentrations than wild-type TNFR1 (Figure 6D). These results confirmed our conclusions that aa 371-386 of LMP1 make up a self-sufficient, viral TRADD-binding domain which encodes a unique and nonapoptotic type of TRADD signaling.
###end p 59
###begin title 60
TNFR1 Is Converted into a Nonapoptotic Receptor upon Replacement of Its Death Domain by the TRADD-Binding Site of LMP1
###end title 60
###begin p 61
(A) Schematic depiction of the chimeras.
###end p 61
###begin p 62
(B) Ectopic expression of the indicated constructs in TNFR1/TNFR2 double-negative MEFs, detected by the anti-TNFR1 (H5) antibody.
###end p 62
###begin p 63
(C) Both TNFR1 wild type and TNFR1-LTB induce NF-kappaB. NF-kappaB reporter assays in TNFR1/TNFR2 double-negative MEFs are shown. Data have been corrected for protein expression levels of TNFR1 constructs and are mean values of three independent experiments +/- standard deviation.
###end p 63
###begin p 64
(D) TNFR1, but not TNFR1-LTB, induces apoptosis. TNFR1/TNFR2 double-negative MEFs were electroporated with the indicated amounts of constructs together with GFP. Five h post transfection, the cells were stained with Annexin V-Cy5 (AnV-Cy5) and analyzed by flow cytometry. AnV-Cy5+/GFP+ staining indicated apoptosis induced by the transfected constructs. In (C) and (D), the cells were incubated with 2 muM zVAD-fmk (zVAD) throughout the experiment where indicated.
###end p 64
###begin title 65
Discussion
###end title 65
###begin p 66
###xml 757 759 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b035">35</xref>
###xml 760 762 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b036">36</xref>
###xml 972 974 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b037">37</xref>
###xml 1026 1028 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b038">38</xref>
###xml 1141 1143 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b039">39</xref>
###xml 1271 1273 1255 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b040">40</xref>
###xml 1274 1276 1258 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b041">41</xref>
###xml 1419 1421 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b041">41</xref>
###xml 124 127 <span type="species:ncbi:10376">EBV</span>
###xml 315 318 <span type="species:ncbi:10376">EBV</span>
###xml 582 585 <span type="species:ncbi:10376">EBV</span>
###xml 726 729 <span type="species:ncbi:10376">EBV</span>
###xml 824 827 <span type="species:ncbi:10376">EBV</span>
###xml 998 1001 <span type="species:ncbi:10116">rat</span>
###xml 1226 1229 <span type="species:ncbi:10116">rat</span>
###xml 1338 1347 <span type="species:ncbi:10090">nude mice</span>
Our results provide definite evidence that the cellular pro-apoptotic TRADD protein is a critical signaling mediator of the EBV oncoprotein LMP1, and they show that DNA tumor viruses have developed means to modulate the molecular and functional properties of cellular signaling molecules. We have demonstrated that EBV masks TRADD's pro-apoptotic activity and that this unique viral function is intrinsically encoded by the TRADD-binding domain of the LMP1 molecule. Moreover, this property of the 16 C-terminal amino acids of LMP1 is transferable to other receptors such as TNFR1. EBV exploits TRADD for NF-kappaB signaling by LMP1-CTAR2, which contributes important growth factor-like signals for efficient proliferation of EBV-transformed B lymphocytes [35,36]. Quantitative analysis has revealed that a recombinant maxi-EBV harboring a LMP1(Y384G) mutant has a approximately90% reduced potential of inducing long-term B cell proliferation compared to wild-type virus [37]. LMP1 also transforms rat fibroblasts in culture [38]. Whereas CTAR1 but not CTAR2 was the essential domain for in vitro transformation of Rat1 cells in one report [39], other studies supported a critical role of CTAR2 in oncogenic transformation of rat fibroblasts in vitro as well as in vivo [40,41]. Notably, tumor formation by LMP1-transformed Rat1 cells in nude mice essentially requires NF-kappaB activity and a functional CTAR2 domain [41]. According to our data, it is therefore highly likely that TRADD is critically involved in mediating these functions of CTAR2, extending the biological spectrum of TRADD activity to cell proliferation and transformation.
###end p 66
###begin p 67
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b002">2</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b011">11</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b014">14</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b015">15</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b019">19</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b011">11</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b019">19</xref>
###xml 728 733 728 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 760 765 760 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 1041 1046 1033 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 779 784 <span type="species:ncbi:9606">human</span>
###xml 858 863 <span type="species:ncbi:9606">human</span>
###xml 902 905 <span type="species:ncbi:10376">EBV</span>
So far, studies on the role of TRADD in LMP1 signaling were solely based on the overexpression of TRADD and TRADD mutants, or RNAi-mediated knockdown of TRADD [2,11,14,15,19]. Such experiments yielded conflicting results with respect to the potential role of TRADD in LMP1 signal transduction (see Introduction). The knockdown of TRADD in HEK293 epithelial cells even suggested that TRADD is fully dispensable for LMP1 signaling [11,19], although residual TRADD protein might have rescued pathway activities in RNAi experiments. Alternatively, this result might reflect different cell type-specific functions of TRADD. To be able to investigate TRADD's molecular role in LMP1 signaling in a clean genetic system, we generated a TRADD knockout by deleting both TRADD alleles from human DG75 B lymphocytes. This is a biologically relevant cell system, because human B lymphocytes are the target cells of EBV. DG75 cells also express TNFR1 and readily responded to TNFalpha stimulation with activation of the NF-kappaB pathway. The knockout of TRADD abrogated TNFalpha-mediated NF-kappaB activation in DG75 cells, demonstrating that TNFR1 activation of the canonical NF-kappaB pathway critically depends on TRADD and that TRADD signaling is intact in DG75 cells.
###end p 67
###begin p 68
###xml 254 256 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b011">11</xref>
###xml 379 380 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b005">5</xref>
###xml 507 509 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b042">42</xref>
###xml 863 865 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b025">25</xref>
###xml 866 868 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b026">26</xref>
###xml 869 871 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b030">30</xref>
###xml 1006 1008 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b028">28</xref>
###xml 1086 1088 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b010">10</xref>
###xml 1089 1091 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b029">29</xref>
The molecular mechanisms by which CTAR2 of LMP1 activates NF-kappaB are poorly understood. It has been unclear which direct interaction partners of CTAR2 mediate NF-kappaB activation. TRADD was believed to be dispensable for LMP1 signaling to NF-kappaB [11]. TRAF3 and TRAF6 are required for NF-kappaB activation by CTAR2, but TRAF molecules do not interact with CTAR2 directly [5]. In addition, knockdown of BS69, a potential mediator of TRAF6 binding to CTAR2, did not affect LMP1 signaling to NF-kappaB [42]. Here we demonstrate that the CTAR2 domain of LMP1 recruits IKKbeta for signaling and that IKKbeta recruitment and, thus, activation by LMP1 depends on TRADD. In TNFR1 signaling, activation of IKKbeta can be functionally separated from its recruitment to the signaling complex. IKKbeta directly binds to TRAF2, which gets recruited to TNFR1 via TRADD [25,26,30]. The activation of IKKbeta requires the interaction of IKKgamma, the regulatory subunit of the IKK complex, with ubiquitinated RIP1 [28]. In contrast, TRAF2, RIP1, and IKKgamma are dispensable for LMP1 signaling [10,29].
###end p 68
###begin p 69
###xml 244 252 234 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g007">Figure 7</xref>
###xml 492 494 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b010">10</xref>
###xml 690 692 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b043">43</xref>
###xml 856 858 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b044">44</xref>
###xml 1227 1229 1192 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b042">42</xref>
###xml 1355 1357 1320 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b045">45</xref>
How does NF-kappaB signaling at CTAR2 work? We propose a mechanism of IKKbeta activation at CTAR2 that involves two pathways: a TRADD-dependent IKKbeta recruitment pathway and a parallel activation pathway that is critically mediated by TRAF6 (Figure 7). Such a mechanism resolves the paradox that TRADD is solely required for CTAR2-triggered NF-kappaB signaling, whereas TRAF6 is essential for both NF-kappaB and JNK activation. Because TRAF2 is dispensable for NF-kappaB induction by LMP1 [10], a yet-undefined factor must be postulated that bridges IKKbeta binding to TRADD in LMP1 signaling. We exclude TRAF3 or TRAF6 as candidates, because TRADD has affinity for only TRAF1 and TRAF2 [43], and we did not detect TRAF3 or TRAF6 in immunoprecipitations together with TRADD and IKKbeta (unpublished data). Potential candidates might include p62/PKCzeta [44]. Despite their role in canonical NF-kappaB signaling, a physical and/or functional interaction of TRAF3 and TRAF6 with CTAR2 must be independent of TRADD, because both TRAFs are critical for JNK activation by CTAR2, which is still intact in TRADD-/- cells. The transcriptional corepressor BS69 was suggested as the potential mediator of TRAF6 interaction with CTAR2 [42], although a recent report showed that endogenous BS69 is exclusively located within the nucleus interacting with chromatin [45]. However, cytoplasmic BS69 protein levels beyond the detection limit of the applied BS69 antibody possibly suffice to mediate LMP1 signaling. It is also conceivable that additional and yet-unknown factors might be involved in mediating the interaction of TRAFs with CTAR2.
###end p 69
###begin title 70
Schematic Model of TRADD's Role in Nonapoptotic Signaling Induced by the TRADD-Binding Domain of LMP1
###end title 70
###begin p 71
The unique interaction of the 16 C-terminal amino acids of LMP1 (LTB) with TRADD prevents apoptosis induction through TRADD, which is an intrinsic and transferable function of LTB. Additional LMP1 sequences are not required for masking TRADD's apoptotic activity. TRADD mediates the recruitment of IKKbeta to the LMP1 signaling complex through a yet unidentified factor. Activation of IKKbeta requires a parallel pathway that is dependent on TRAF6. TRAF6 activation of IKKbeta most likely involves TAK1 and TAB1 (not depicted). The JNK pathway is TRADD-independent and works through TRAF6 and, probably, BS69. To keep this model concise, only key molecules of CTAR2 signaling are shown. Refer to the text for more details.
###end p 71
###begin p 72
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b022">22</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b022">22</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b024">24</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b030">30</xref>
###xml 328 336 324 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060008-g005">Figure 5</xref>
###xml 339 340 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b005">5</xref>
###xml 341 343 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b029">29</xref>
###xml 521 523 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b035">35</xref>
###xml 524 526 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b037">37</xref>
###xml 490 493 <span type="species:ncbi:10376">EBV</span>
###xml 661 664 <span type="species:ncbi:10376">EBV</span>
Upon overexpression, TRADD is a highly apoptotic protein [22]. In TNFR1 signaling, TRADD mediates the activation of caspase-dependent apoptosis through FADD [22,24,30]. In contrast, LMP1 is a transforming protein with anti-apoptotic properties that does not induce programmed cell death, even if NF-kappaB signaling is blocked (Figure 5) [5,29]. We showed here that TRADD is essential for NF-kappaB induction by CTAR2, a domain that delivers signals critical for long-term proliferation of EBV-transformed B lymphocytes [35,37]. Thus, TRADD has a unique biological role in LMP1-induced cell proliferation and, therefore, contributes to B cell transformation by EBV. How does LMP1 achieve to exploit TRADD without inducing apoptosis? Our results demonstrated that aa 371-386 of LMP1 encompass an autonomous and unique viral TRADD-binding domain that encodes the nonapoptotic properties of TRADD signaling. This domain has no sequence homology to any known TRADD-binding site of cellular receptors or signaling molecules. Accordingly, the interaction between LMP1 and TRADD does not require a functional death domain in either of the two molecules. Our data demonstrated that this unique molecular structure of the LMP1-TRADD complex is intrinsically determined by the TRADD-binding site of LMP1 and can be transferred together with the nonapoptotic phenotype of TRADD signaling to TNFR1. Therefore, the unique interaction of TRADD with the TRADD-binding site of LMP1 must prevent apoptosis induction by TRADD. Accordingly, we could not detect an interaction of TRADD with the apoptosis mediator FADD in the presence of LMP1 (unpublished data). Sequences within the TRADD death domain, which are required for apoptosis induction, might be masked by components of the LMP1-TRADD complex. Based on our domain-swapping experiments, we can further exclude the possibility that signals originating elsewhere at the LMP1 signaling domain, for instance at CTAR1, are required to suppress apoptosis induction by TRADD, because the 16 C-terminal amino acids of LMP1 did not induce apoptosis in the context of wild-type TNFR1.
###end p 72
###begin p 73
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b046">46</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b020">20</xref>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b033">33</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b047">47</xref>
We also showed that LMP1 and its anticipated functional analogue, CD40, substantially differ in their receptor-proximal mechanisms activating signal transduction. Very much in contrast to LMP1, CD40 does not require TRADD for signaling. Thus, although both molecules share similarities regarding their role in supporting B-cell proliferation [46], they work through different receptor-proximal signaling molecules. This is in line with previous observations that LMP1 assembles a more efficient signaling complex than CD40 and that LMP1, but not CD40, signaling is dependent on TRAF3 [20,33,47].
###end p 73
###begin p 74
###xml 282 287 <span type="species:ncbi:9606">human</span>
###xml 304 307 <span type="species:ncbi:10376">EBV</span>
In summary, our experiments defined an essential and unique role for TRADD in signaling of the viral oncoprotein LMP1. The viral TRADD-binding site of LMP1 determines the nonapoptotic and TRAF6-dependent type of TRADD signaling which leads to the activation of NF-kappaB. Thus, the human DNA tumor virus EBV has developed strategies to alter the functional and molecular properties of cellular signaling molecules to exploit them for its own purpose of cell transformation.
###end p 74
###begin title 75
Materials and Methods
###end title 75
###begin title 76
Plasmids and cloning.
###end title 76
###begin p 77
###xml 262 264 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b015">15</xref>
###xml 265 267 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b021">21</xref>
###xml 268 270 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b048">48</xref>
###xml 271 273 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b049">49</xref>
###xml 853 858 <span type="species:ncbi:9606">human</span>
###xml 1047 1052 <span type="species:ncbi:9606">human</span>
pHEBO empty vector, pCMV-HA-LMP1 based on pHEBO, pSV-LMP1-CD40, pcDNA3-p35, pRK5 empty vector, pRK-myc-TRADD, pRK-myc-TRADD(296-299A), pCMV-I-kappaBalpha(S32/36A), pcDNA3-Flag-IKKbeta, and the NF-kappaB reporter plasmid 3xkappaBL have been described previously [15,21,48,49]. pEGFP-C1 is commercially available (BD Clontech). The following expression vectors were cloned on the basis of pCMV-HA-LMP1 by PCR approaches: pCMV-HA-LMP1(AAA), pCMV-HA-LMP1(Y384G), pCMV-HA-LMP1Delta194-386, pCMV-HA-LMP1Delta371-386 and pCMV-HA-LMP1(AAA/Delta371-386). The LMP1-TNFR1 fusion was generated by overlap-extension PCR and cloned into the background of pCMV-HA-LMP1 to obtain pCMV-HA-LMP1-TNFR1. The vectors pCMV-HA-LMP1-TNFR1DeltaDD and pCMV-HA-LMP1-TNFR1-LTB were generated by PCR approaches based upon pCMV-HA-LMP1-TNFR1. To generate pRK5-TNFR1, the sequence of human TNFR1 was amplified by PCR from a TNFR1 cDNA (kind gift from H. Wajant) and cloned into pRK5. pRK5-TNFR1DeltaDD and pRK5-TNFR1-LTB were cloned by PCR approaches. To generate pRK5-HA-JNK1, human JNK1alpha1 cDNA (kind gift from M. Karin) was N-terminally fused with a hemagglutinin (HA)-tag by PCR and cloned into pRK5. All constructs were verified by sequencing.
###end p 77
###begin title 78
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 24 29 <span type="species:ncbi:9606">human</span>
TRADD gene targeting in human B lymphocytes.
###end title 78
###begin p 79
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 600 605 600 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 616 617 616 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 825 827 823 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1201 1206 1198 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 1305 1307 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b050">50</xref>
###xml 1414 1419 1411 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 747 751 <span type="species:ncbi:9913">calf</span>
The human TRADD gene was cloned from the blood cell PAC library RPCI,3-5 (P. de Jong, Roswell Park Cancer Institute). A 13,702-bp EcoRI fragment of the clone RPCIP704M111012 encompassing the complete TRADD gene was partially sequenced and subcloned into pACYC184, resulting in the vector pACYC184-1012.4. Based on this TRADD clone, we constructed the gene targeting vectors pTRADDko.1 and pTRADDko.2. The 5' homologous arms of both vectors were identical, whereas the constructs differed in their 3' arms homologous to the TRADD gene to prevent recombination of pTRADDko.2 with the already disrupted TRADD allele. 107 DG75 cells were electroporated with 20 mug of linearized pTRADDko.1. The cells were selected in RPMI medium containing 10% fetal calf serum in the presence of 50% cell-free pre-conditioned medium, 400 mug ml-1 hygromycin B and 40 muM ganciclovir (Cymeven, Hoffmann-La-Roche) for simultaneous positive and negative selection. Successful gene targeting was verified by Southern blot analysis of EcoRI-digested cellular DNA using the external probe 1 and the internal probe 2. Subsequently, the hygromycin-resistance (Hyg-R) and GFP expression cassettes were removed from the disrupted TRADD gene locus by Cre-mediated recombination. Due to the use of the modified loxP66 and loxP71 sites [50], no functional loxP sequence resided in the genome after Cre reaction. To target the remaining wild-type TRADD allele, resulting TRADD+/- clones were subjected to a second gene targeting round using the pTRADDko.2 vector.
###end p 79
###begin title 80
Immunoprecipitation, immunoblotting, and antibodies.
###end title 80
###begin p 81
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1171 1173 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b037">37</xref>
###xml 1308 1310 1298 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b051">51</xref>
###xml 1047 1052 <span type="species:ncbi:9606">human</span>
###xml 1091 1094 <span type="species:ncbi:10376">EBV</span>
###xml 1706 1708 <span type="species:ncbi:34205">M2</span>
###xml 1726 1731 <span type="species:ncbi:10090">mouse</span>
107 DG75 cells were electroporated in a BioRad Gene Pulser at 240 V and 975 muF with 5 mug of the indicated LMP1 constructs and 1 mug Flag-IKKbeta. Total transfected DNA was adjusted to 18 mug with inert DNA. Five transfection samples were pooled per immunoprecipitation. Twenty-four h post transfection, the cells were lysed in IP-lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 0.1% NP40, 5 mM EDTA, Roche protease inhibitor cocktail). HA-tagged proteins were immunoprecipitated by the anti-HA (12CA5) antibody (Roche) which had been covalently coupled to protein A sepharose beads (Amersham) using dimethyl pimelimidate (Pierce). After immunoprecipitation, beads were washed three times with IP-lysis buffer and precipitated proteins were analyzed on immunoblots. HEK293 cells were transfected in five 10-cm dishes per immunoprecipitation with 3.5 mug of LMP1 constructs, 0.5 mug of TRADD constructs, and 1.5 mug of pcDNA3-p35 using the polyfect reagent (Qiagen). LCL 3 lymphoblastoid cells were generated by in vitro transformation of primary human B lymphocytes with a recombinant maxi-EBV in which the wild-type LMP1 gene had been replaced by HA-LMP1 as described [37]. HA-LMP1 was immunoprecipitated from LCL 3 lysates using anti-HA (12CA5)-coupled protein A sepharose beads (see above). The LCL 721 [51] expressing untagged LMP1 was used as a control. For standard immunoblotting, cells were lysed in IP-lysis buffer containing 0.1% NP40 as a detergent (see above). The following primary antibodies were used: Actin (I-19), CD40 (C-20), I-kappaBalpha (C-21), IKKbeta (H-470), JNK1 (C-17), TNFR1 (H-5), TRADD (H-278), alphaTubulin (B-5-1-2) (all from Santa Cruz Biotech.), HA (12CA5) (Roche), Flag (M2) (Sigma), TRADD (mouse, BD Transduction Lab.), and phospho-I-kappaBalpha(Ser32) (New England Biolabs).
###end p 81
###begin title 82
Isolation of membrane lipid rafts.
###end title 82
###begin p 83
###xml 383 385 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b052">52</xref>
For lipid raft recruitment assays, HEK293 cells were transfected with the indicated constructs in 10-cm dishes. Twenty-four h post transfection, the cells were lysed in TXNE buffer (25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, Roche protease inhibitor cocktail) at 4 degreesC and subsequently fractionated in an OptiPrep (Progen) density gradient as described [52]. Membrane lipid rafts were found enriched in the second fraction from top out of eight 500-mul fractions. The raft-specific sphingolipid GM1 served as a raft marker and was detected on dot blots using HRP-coupled cholera toxin subunit B (Sigma).
###end p 83
###begin title 84
Immunocomplex kinase assay.
###end title 84
###begin p 85
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 285 290 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 361 362 350 351 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 450 452 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b021">21</xref>
###xml 583 585 <span type="species:ncbi:34205">M2</span>
5 x 106 DG75 cells were electroporated with 5 mug of the indicated constructs together with 3 mug of pRK5-HA-JNK1 for JNK assays or with 2 mug of the LMP1 constructs and 5 mug of pcDNA3-Flag-IKKbeta for IKKbeta assays. GFP and p35 were co-transfected. To rescue TRADD expression, DG75 TRADD-/- cells were co-transfected with 1 mug of pACYC184-1012.4 (see above). Total amounts of transfected DNA were adjusted to 15 mug with inert DNA. As described [21], the cells were lysed 24 h post transfection, HA-JNK1 or Flag-IKKbeta was immunoprecipitated by the anti-HA (3F10) or anti-Flag (M2) antibodies, respectively, and immunocomplex kinase assays were performed using purified GST-c-Jun or GST-I-kappaBalpha as substrates.
###end p 85
###begin title 86
Cell death assay in B lymphocytes.
###end title 86
###begin p 87
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 414 416 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b031">31</xref>
###xml 693 695 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b031">31</xref>
3 x 106 B lymphocytes were electroporated in a Bio-Rad gene pulser with 10 mug of the indicated LMP1 constructs together with 1 mug of pEGFP-C1 and 3 mug of pCMV-I-kappaBalpha(S32/36A) to block the NF-kappaB pathway. Twenty-four h post transfection, the cells were stained with propidium iodide (PI), and GFP+/PI- cells were quantified by flow cytometry in a FACSCalibur cytometer (Becton Dickinson) as described [31]. The number of successfully transfected viable cells (GFP+/PI-) in the empty vector reference was set to 100% survival. The reduction of green living cells in a test sample versus the reference was a direct measure for the cell death rate induced by the co-transfected gene [31].
###end p 87
###begin title 88
Apoptosis assay.
###end title 88
###begin p 89
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 39 41 39 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b053">53</xref>
107 TNFR1/TNFR2 double-deficient MEFs [53] were electroporated at 240 V and 975 muF in a BioRad Gene Pulser with the given amounts of the indicated TNFR1 constructs together with pEGFP-C1. Total transfected DNA was adjusted to 16 mug with inert DNA. Six h post transfection, the cells were stained with Cy5-labeled annexin V (Biocat) and analyzed for GFP expression and annexin V staining by flow cytometry. AnV-Cy5+/GFP+ cells were indicative for successfully transfected cells undergoing apoptosis.
###end p 89
###begin title 90
Reporter assay.
###end title 90
###begin p 91
###xml 22 24 22 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b054">54</xref>
###xml 314 315 303 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 423 425 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060008-b021">21</xref>
###xml 430 431 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
TRAF6-deficient MEFs [54] and HEK293 cells were transfected in six-well plates with the indicated constructs together with pcDNA3-p35, the NF-kappaB reporter 3xkappaBL, and CMVbetaGal (BD Clontech) using Polyfect (Qiagen). Twenty-four h post transfection, the cells were lysed in luciferase lysis buffer (100 mM KPi, pH 7.8, 1 mM DTT, 1% Triton X-100). Firefly luciferase and beta-galactosidase were measured as described [21]. 107 TNFR1/TNFR2 double-deficient MEFs were electroporated with the indicated constructs together with the NF-kappaB reporter 3xkappaBL and pCMV-RL (Promega). Twenty-four h post transfection, firefly and renilla luciferase activities were measured and analyzed using the Dual-Luciferase reporter assay system (Promega). Luciferase activities were standardized for beta-galactosidase or renilla luciferase activities, respectively.
###end p 91
###begin title 92
Supporting Information
###end title 92
###begin title 93
The TRADD-binding domain of LMP1 Induces JNK Signaling in the Context of the TNFR1 Signaling Domain
###end title 93
###begin p 94
HEK293 cells were transfected with the indicated constructs together with HA-JNK1. In addition, the cells were incubated with 2 muM zVAD-fmk to inhibit apoptosis induced by HA-LMP1-TNFR1. Twenty-four h post transfection, HA-JNK1 was immunoprecipitated from cell lysates and HA-JNK1 immunocomplex kinase assays were performed using GST-c-Jun as a substrate. Phosphorylation levels were quantified using a phosphoimager.
###end p 94
###begin p 95
(845 KB TIF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin title 97
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 56 59 <span type="species:ncbi:10376">EBV</span>
Quantitative Results of the TRADD Gene Targeting in the EBV-negative B Cell Lines DG75, BJAB, and BL2
###end title 97
###begin p 98
(43 KB PDF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin title 100
Accession Numbers
###end title 100
###begin p 101
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRADD</italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
The GenBank () accession number for human TRADD gene is AY995114.
###end p 101
###begin p 102
###xml 451 454 <span type="species:ncbi:10376">EBV</span>
We thank Michael Karin, Jun-Hsiang Lin, Stephan Ludwig, Lois K. Miller, and Harald Wajant for plasmids; Tak W. Mak for TRAF6-deficient fibroblasts; and Daniela Mannel for TNFR1/TNFR2-double deficient fibroblasts. We are grateful to Ellen Krautkramer and Oliver T. Fackler for advice with lipid raft preparations; to Marcus Conrad and Sabine Maier for helpful discussions; and to Wolfgang Hammerschmidt for help with the generation of recombinant maxi-EBV.
###end p 102
###begin title 103
Abbreviations
###end title 103
###begin p 104
amino acids
###end p 104
###begin p 105
C-terminal activating region
###end p 105
###begin p 106
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus
###end p 106
###begin p 107
Fas-associated death domain protein
###end p 107
###begin p 108
I-kappaB kinase beta
###end p 108
###begin p 109
c-Jun N-terminal kinase
###end p 109
###begin p 110
lymphoblastoid cell line
###end p 110
###begin p 111
latent membrane protein 1
###end p 111
###begin p 112
LMP1 TRADD-binding site
###end p 112
###begin p 113
###xml 0 5 <span type="species:ncbi:10090">mouse</span>
mouse embryonic fibroblast
###end p 113
###begin p 114
tumor necrosis factor
###end p 114
###begin p 115
TNF-receptor 1
###end p 115
###begin p 116
TNF-receptor 1-associated death domain protein
###end p 116
###begin p 117
TNFR-associated factor
###end p 117
###begin title 118
References
###end title 118
###begin article-title 119
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus: 40 years on
###end article-title 119
###begin article-title 120
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB
###end article-title 120
###begin article-title 121
Signal transduction by tumor necrosis factor and its relatives
###end article-title 121
###begin article-title 122
###xml 29 47 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule
###end article-title 122
###begin article-title 123
###xml 27 45 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Signal transduction by the Epstein-Barr virus oncogene latent membrane protein 1 (LMP1)
###end article-title 123
###begin article-title 124
###xml 29 47 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52
###end article-title 124
###begin article-title 125
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway
###end article-title 125
###begin article-title 126
###xml 44 62 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines
###end article-title 126
###begin article-title 127
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation
###end article-title 127
###begin article-title 128
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6
###end article-title 128
###begin article-title 129
###xml 42 60 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1
###end article-title 129
###begin article-title 130
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade
###end article-title 130
###begin article-title 131
###xml 62 80 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)
###end article-title 131
###begin article-title 132
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2
###end article-title 132
###begin article-title 133
LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2
###end article-title 133
###begin article-title 134
###xml 81 99 <span type="species:ncbi:10376">Epstein-Barr virus</span>
TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40
###end article-title 134
###begin article-title 135
###xml 108 126 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus
###end article-title 135
###begin article-title 136
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation
###end article-title 136
###begin article-title 137
###xml 63 81 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Elucidation of the c-Jun N-terminal kinase pathway mediated by Epstein-Barr virus-encoded latent membrane protein 1
###end article-title 137
###begin article-title 138
Requirement for TRAF3 in Signaling by LMP1 But Not CD40 in B Lymphocytes
###end article-title 138
###begin article-title 139
TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1
###end article-title 139
###begin article-title 140
The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation
###end article-title 140
###begin article-title 141
Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction
###end article-title 141
###begin article-title 142
Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1
###end article-title 142
###begin article-title 143
The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation
###end article-title 143
###begin article-title 144
The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF
###end article-title 144
###begin article-title 145
Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation
###end article-title 145
###begin article-title 146
Ubiquitin signalling in the NF-kappaB pathway
###end article-title 146
###begin article-title 147
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation
###end article-title 147
###begin article-title 148
TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
###end article-title 148
###begin article-title 149
A novel assay to quantify cell death after transient expression of apoptotic genes in B- and T-lymphocytes
###end article-title 149
###begin article-title 150
###xml 26 29 <span type="species:ncbi:10376">EBV</span>
High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells
###end article-title 150
###begin article-title 151
CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex
###end article-title 151
###begin article-title 152
Systematic mutational analysis of the death domain of the tumor necrosis factor receptor 1-associated protein TRADD
###end article-title 152
###begin article-title 153
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues
###end article-title 153
###begin article-title 154
###xml 3 21 <span type="species:ncbi:10376">Epstein-Barr virus</span>
An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation
###end article-title 154
###begin article-title 155
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 94 112 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Latent membrane protein 1 is critical for efficient growth transformation of human B cells by Epstein-Barr virus
###end article-title 155
###begin article-title 156
###xml 3 6 <span type="species:ncbi:10376">EBV</span>
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
###end article-title 156
###begin article-title 157
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K
###end article-title 157
###begin article-title 158
###xml 25 43 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 117 120 <span type="species:ncbi:10116">rat</span>
All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts
###end article-title 158
###begin article-title 159
###xml 98 101 <span type="species:ncbi:10116">rat</span>
Nuclear factor-kappaB activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts
###end article-title 159
###begin article-title 160
BS69, a Specific Adaptor in the Latent Membrane Protein 1-Mediated c-Jun N-Terminal Kinase Pathway
###end article-title 160
###begin article-title 161
All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction
###end article-title 161
###begin article-title 162
The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation
###end article-title 162
###begin article-title 163
New insights into BS69 functions
###end article-title 163
###begin article-title 164
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor
###end article-title 164
###begin article-title 165
LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling
###end article-title 165
###begin article-title 166
###xml 19 24 <span type="species:ncbi:9606">human</span>
Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli
###end article-title 166
###begin article-title 167
Activation of the Ikappa B kinases by RIP via IKKgamma /NEMO-mediated oligomerization
###end article-title 167
###begin article-title 168
Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome
###end article-title 168
###begin article-title 169
Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells
###end article-title 169
###begin article-title 170
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts
###end article-title 170
###begin article-title 171
Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles
###end article-title 171
###begin article-title 172
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
###end article-title 172
###begin p 173
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. FS and AK conceived and designed the experiments. FS, JN, JG, NL, HK, CB, and AK performed the experiments. FS, JN, JG, CB, and AK analyzed the data. AK wrote the paper.
###end p 173
###begin p 174
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported by grants of the Helmholtz-Gemeinschaft (Strategy Fonds 2000: Viral Regulating Factors), the Deutsche Forschungsgemeinschaft (DFG) (Ki 825/1 and SFB 455) to AK, and by institutional grants.
###end p 174
###begin p 175
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 175

